These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 32151970)
1. Neurofilaments in disease: what do we know? Gordon BA Curr Opin Neurobiol; 2020 Apr; 61():105-115. PubMed ID: 32151970 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study. Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080 [TBL] [Abstract][Full Text] [Related]
3. [Neurofilaments: a key new biomarker for clinicians. Part 2: Neurofilaments, an asset beyond neurodegenerative diseases]. Delaby C; Bousiges O; Bouvier D; Fillée C; Fourier A; Mondésert É; Nezry N; Omar S; Quadrio I; Rucheton B; Schraen-Maschke S; van Pesch V; Vicca S; Lehmann S; Bedel A Ann Biol Clin (Paris); 2022 Sep; 80(5):441-450. PubMed ID: 36453743 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature. Gagliardi D; Meneri M; Saccomanno D; Bresolin N; Comi GP; Corti S Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450699 [TBL] [Abstract][Full Text] [Related]
5. Neurofilaments and tau proteins in cerebrospinal fluid and serum in dementias and neuroinflammation. Fialova L; Bartos A; Svarcova J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):286-295. PubMed ID: 28947837 [TBL] [Abstract][Full Text] [Related]
6. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis. Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388 [TBL] [Abstract][Full Text] [Related]
7. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS. Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339 [TBL] [Abstract][Full Text] [Related]
8. Neurofilament Levels in Dendritic Spines Associate with Synaptic Status. Gürth CM; do Rego Barros Fernandes Lima MA; Macarrón Palacios V; Cereceda Delgado AR; Hubrich J; D'Este E Cells; 2023 Mar; 12(6):. PubMed ID: 36980250 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of CSF neurofilament light and heavy chain protein in MS. Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylated neurofilament heavy chain: a potential diagnostic biomarker in amyotrophic lateral sclerosis. Heckler I; Venkataraman I J Neurophysiol; 2022 Mar; 127(3):737-745. PubMed ID: 35138963 [TBL] [Abstract][Full Text] [Related]
11. Neurofilaments in progressive multiple sclerosis: a systematic review. Williams T; Zetterberg H; Chataway J J Neurol; 2021 Sep; 268(9):3212-3222. PubMed ID: 32447549 [TBL] [Abstract][Full Text] [Related]
12. Anti-neurofilament antibodies and neurodegeneration: Markers and generators. Zmira O; Halpern AI; Drori T J Neuroimmunol; 2020 Jul; 344():577248. PubMed ID: 32344161 [TBL] [Abstract][Full Text] [Related]
13. Neurofilaments in neurologic disorders and beyond. Mak G; Menon S; Lu JQ J Neurol Sci; 2022 Oct; 441():120380. PubMed ID: 36027641 [TBL] [Abstract][Full Text] [Related]
14. Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis. Verberk IMW; Koel-Simmelink M; Twaalfhoven H; Vrenken H; Korth C; Killestein J; Teunissen CE; Bridel C Mult Scler Relat Disord; 2021 May; 50():102840. PubMed ID: 33626430 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies. Baumgartner D; Mazanec R; Hanzalová J J Neurol; 2023 Mar; 270(3):1600-1614. PubMed ID: 36456758 [TBL] [Abstract][Full Text] [Related]
16. Neurofilaments as biomarkers in neurological disorders - towards clinical application. Khalil M; Teunissen CE; Lehmann S; Otto M; Piehl F; Ziemssen T; Bittner S; Sormani MP; Gattringer T; Abu-Rumeileh S; Thebault S; Abdelhak A; Green A; Benkert P; Kappos L; Comabella M; Tumani H; Freedman MS; Petzold A; Blennow K; Zetterberg H; Leppert D; Kuhle J Nat Rev Neurol; 2024 May; 20(5):269-287. PubMed ID: 38609644 [TBL] [Abstract][Full Text] [Related]
17. Neurofilament results for the phase II neuroprotection study of phenytoin in optic neuritis. Raftopoulos R; Kuhle J; Grant D; Hickman SJ; Altmann DR; Leppert D; Blennow K; Zetterberg H; Kapoor R; Giovannoni G; Gnanapavan S Eur J Neurol; 2021 Feb; 28(2):587-594. PubMed ID: 33058438 [TBL] [Abstract][Full Text] [Related]
19. Neurofilaments in health and disease. Julien JP; Mushynski WE Prog Nucleic Acid Res Mol Biol; 1998; 61():1-23. PubMed ID: 9752717 [TBL] [Abstract][Full Text] [Related]
20. Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled Trial. Williams TE; Holdsworth KP; Nicholas JM; Eshaghi A; Katsanouli T; Wellington H; Heslegrave A; Zetterberg H; Frost C; Chataway J Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 35031587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]